Citigroup Inc 10x Genomics, Inc. Call Options Transaction History

Citigroup Inc

  • $153 Billion
  • Q2 2024

Call Options

4 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q4 2022

Feb 09, 2023
BUY
$24.4 - $41.3 $517,279 - $875,559
21,200 New
21,200 $772,000
Q2 2022

Aug 10, 2022
BUY
$36.95 - $82.41 $2.17 Million - $4.83 Million
58,600 Added 95.13%
120,200 $5.44 Million
Q1 2022

May 12, 2022
BUY
$55.7 - $145.79 $1.93 Million - $5.04 Million
34,600 Added 128.15%
61,600 $4.69 Million
Q4 2021

Feb 10, 2022
BUY
$135.05 - $182.59 $3.65 Million - $4.93 Million
27,000 New
27,000 $4.02 Million

Others Institutions Holding TXG

# of Institutions
287
Shares Held
94.9M
Call Options Held
162K
Put Options Held
107K
View Full List

About 10x Genomics, Inc.

TXG Quotes by TradingView
  • Ticker TXG
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Health Information Services
  • Shares Outstandng 95,046,400
  • Market Cap $1.54B
  • Description
  • 10x Genomics, Inc., a life science technology company, develops and sells instruments, consumables, and software for analyzing biological systems in North America, Europe, the Middle East, Africa, China, and the Asia Pacific. The company provides chromium and chromium connect instruments, microfluidic chips, slides, reagents, and other consumabl...
More about TXG
Track This Portfolio

Track Citigroup Inc Portfolio

Follow Citigroup Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Citigroup Inc, based on Form 13F filings with the SEC.

News

Stay updated on Citigroup Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email